Lung Cancer News and Research

Latest Lung Cancer News and Research

Alectinib promise for crizotinib-resistant NSCLC

Alectinib has shown promising antitumour activity in patients with ALK-rearranged non-small-cell lung cancer that is resistant to crizotinib, researchers report.

23 Sep 2014

Circulating tumour cell clinical research collaboration announced between EKF Diagnostics and Massachusetts General Hospital

EKF, announces that it has entered into a two year research collaboration with Massachusetts General Hospital.

From EKF Diagnostics 23 Sep 2014

Viewpoints: CHIP funding needed; GOP's flawed plan to make 'the pill' OTC; millennials' health issues

Federal financing for a beneficial health insurance program for low-income children, known as the Children's Health Insurance Program or CHIP, will run out next year unless Congress agrees to extend it. Bills are pending in both the House and the Senate to extend financing for four years, to 2019. Congress should approve the extension in the lame-duck session after the midterm elections so that families and state officials will know what the future holds. The program needs to be maintained amid uncertainty as to whether other good coverage will be available for these children (9/21).

23 Sep 2014

Olympus signs agreement with Brainlab to become exclusive U.S. distributor of Kick Navigation

Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, among other core businesses, announced today it has reached a deal with Munich-based Brainlab to be the exclusive U.S. distributor of Kick Navigation.

From Evident Corporation - Life Sciences 22 Sep 2014

Disrupting cancer regulator MYC: an interview with Professor Kim Janda

MYC is an oncogenic member of the basic helix-loop-helix-leucine zipper transcription factor family. In its monomeric form, MYC’s tertiary structure is intrinsically disordered and the protein is transcriptionally inactive.

17 Sep 2014

Ramucirumab effective second-line option for NSCLC

The monoclonal antibody ramucirumab, when added to second-line docetaxel, significantly improves the overall survival of patients with stage IV non-small-cell lung cancer, show the findings of the REVEL trial.

17 Sep 2014

Survival benefits with erlotinib plus bevacizumab in EGFR-Mutated NSCLC

Combining erlotinib with bevacizumab could prolong progression-free survival in patients being treated for epidermal growth factor receptor-mutated non-small-cell lung cancer, phase II trial results suggest.

17 Sep 2014

S-1 plus radiotherapy shows promise in elderly NSCLC patients

Concurrent administration of S-1 chemotherapy and radiotherapy has a favourable impact on survival in elderly patients with locally advanced non-small-cell lung cancer, a phase II trial has found.

17 Sep 2014

Lobectomy and segmentectomy have similar efficacy in stage I NSCLC

Lobectomy and anatomic segmentectomy appear to offer similar perioperative and oncological outcomes in patients with stage I non-small-cell lung cancer, analysis suggests.

17 Sep 2014

Current smokers at increased risk of developing SPLC

Non-small cell lung cancer (NSCLC) survivors who never smoked or who are former smokers at the time of diagnosis have a lower risk of developing secondary primary lung cancers (SPLC) compared to those who are current smokers, suggesting that increased tobacco exposure is associated with a higher risk of SPLC, according to research presented today at the American Society for Radiation Oncology's 56th Annual Meeting.

17 Sep 2014

OGT to highlight NGS and FISH methods for tumour screening at BSGM 2014

Oxford Gene Technology, The Molecular Genetics Company, is inviting attendees of the British Society for Genetic Medicine annual conference to its seminar entitled ‘Approaches to tumour screening and therapy stratification: case studies in Non-Small Cell Lung Cancer’ on Monday 22nd September, 13.10-13.50, room 2N.

From Oxford Gene Technology 17 Sep 2014

EnGeneIC receives award from Cancer Institute NSW for groundbreaking cancer research

EnGeneIC, Ltd., an emerging biopharmaceutical company focused on revolutionizing the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells, announced that, together with the Asbestos Disease Research Institute, it has received the 2014 Cancer Institute New South Wales Premier’s Award for Excellence in Translational Cancer Research.

17 Sep 2014

Thoracic radiotherapy reduces cancer recurrence in SCLC patients, shows new study

Treating advanced small-cell lung cancer (SCLC) with thoracic (or chest) radiation therapy in addition to standard treatment significantly prolongs long-term survival and reduces cancer recurrence in the chest by almost 50%, according to new research published in The Lancet and being presented simultaneously at ASTRO's 2014 Annual Meeting in San Francisco.

16 Sep 2014

Research roundup: Prevention services for seniors; drug shortages

This policy brief reports the findings of a systematic review conducted by the Community Health Innovations in Prevention for Seniors (CHIPS) project. ... Clinical preventive services such as colorectal cancer screening and pneumococcal immunization can help reduce rates of premature death and disability. Yet, many older adults are not receiving the full set of clinical preventive services that have been proven effective and are considered "high value" in terms of their costs per life saved. Rates are particularly low among racial and ethnic minority older adults compared to national goals.

15 Sep 2014

Lung cancer screening could save thousands, study suggests

Experts from the Centers of Medicare and Medicaid Services (CMS) have weighed up the pros and cons of lung cancer screening to determine whether Medicare-eligible individuals would actually benefit from annual testing.

11 Sep 2014

Cancer Research UK, CRT partner with Asterias to trail novel immunotherapy treatment for lung cancer

CANCER RESEARCH UK and Cancer Research Technology , the charity's development and commercialisation arm, have reached an agreement with Asterias Biotherapeutics, Inc., a biotechnology company in the emerging field of regenerative medicine, to take forward Asterias' novel immunotherapy treatment AST-VAC2 into clinical trials in subjects with non-small cell lung cancer.

11 Sep 2014

New potential therapeutic targets for treatment of pulmonary arterial hypertension

Two new potential therapeutic targets for the treatment of pulmonary arterial hypertension, a deadly disease marked by high blood pressure in the lungs, have been identified by researchers at the University of Illinois at Chicago.

9 Sep 2014

New data from Boehringer's Phase III trial program evaluates efficacy of tiotropium in asthma patients

Boehringer Ingelheim today presented new data from the company's Phase III trial program (UniTinA-asthma®) evaluating tiotropium in asthma, including the first study assessing the efficacy and safety of tiotropium in adolescent patients with symptomatic asthma.

9 Sep 2014

Temperature of exhaled breath could be used to diagnose lung cancer

The temperature of exhaled breath could be used to diagnose lung cancer, according to a new study. The research, presented at the European Respiratory Society (ERS) International Congress in Munich today (8 September 2013), suggests that testing the temperature of breath could be a simple and noninvasive method to either confirm or reject the presence of lung cancer.

8 Sep 2014

Combination miRNA therapy offers promising therapeutic avenue for non-small-cell lung cancer

Micro RNAs (miRNA) have recently emerged as key therapeutic agents against cancers and are actively being evaluated in pre-clinical models of various cancers as well as in human clinical trials.

8 Sep 2014

Lung Cancer News and Research

Latest Lung Cancer News and Research

Alectinib promise for crizotinib-resistant NSCLC

Circulating tumour cell clinical research collaboration announced between EKF Diagnostics and Massachusetts General Hospital

Viewpoints: CHIP funding needed; GOP's flawed plan to make 'the pill' OTC; millennials' health issues

Olympus signs agreement with Brainlab to become exclusive U.S. distributor of Kick Navigation

Disrupting cancer regulator MYC: an interview with Professor Kim Janda

Ramucirumab effective second-line option for NSCLC

Survival benefits with erlotinib plus bevacizumab in EGFR-Mutated NSCLC

S-1 plus radiotherapy shows promise in elderly NSCLC patients

Lobectomy and segmentectomy have similar efficacy in stage I NSCLC

Current smokers at increased risk of developing SPLC

OGT to highlight NGS and FISH methods for tumour screening at BSGM 2014

EnGeneIC receives award from Cancer Institute NSW for groundbreaking cancer research

Thoracic radiotherapy reduces cancer recurrence in SCLC patients, shows new study

Research roundup: Prevention services for seniors; drug shortages

Lung cancer screening could save thousands, study suggests

Cancer Research UK, CRT partner with Asterias to trail novel immunotherapy treatment for lung cancer

New potential therapeutic targets for treatment of pulmonary arterial hypertension

New data from Boehringer's Phase III trial program evaluates efficacy of tiotropium in asthma patients

Temperature of exhaled breath could be used to diagnose lung cancer

Combination miRNA therapy offers promising therapeutic avenue for non-small-cell lung cancer

The ultimate guide to lung research tools and protocols eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in